First Time Loading...

Caribou Biosciences Inc
NASDAQ:CRBU

Watchlist Manager
Caribou Biosciences Inc Logo
Caribou Biosciences Inc
NASDAQ:CRBU
Watchlist
Price: 3.66 USD -3.17% Market Closed
Updated: Apr 30, 2024

Wall Street
Price Targets

CRBU Price Targets Summary
Caribou Biosciences Inc

Wall Street analysts forecast CRBU stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CRBU is 20.4 USD with a low forecast of 10.1 USD and a high forecast of 31.5 USD.

Lowest
Price Target
10.1 USD
176% Upside
Average
Price Target
20.4 USD
457% Upside
Highest
Price Target
31.5 USD
761% Upside
Caribou Biosciences Inc Competitors:
Price Targets
COX
Nicox SA
401% Upside
STOK
Stoke Therapeutics Inc
104% Upside
SPRY
ARS Pharmaceuticals Inc
122% Upside
IVA
Inventiva SA
277% Upside
ZURA
Zura Bio Ltd
261% Upside
TIL
Instil Bio Inc
169% Upside
600201
Jinyu Bio-Technology Co Ltd
10% Upside
EXAI
Exscientia PLC
83% Upside

Revenue
Forecast

Revenue Estimate
Caribou Biosciences Inc

For the last 3 years the compound annual growth rate for Caribou Biosciences Inc's revenue is 41%. The projected CAGR for the next 3 years is 8%.

41%
Past Growth
8%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Caribou Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

Net Income Estimate
Caribou Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-36%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CRBU's stock price target?
Price Target
20.4 USD

According to Wall Street analysts, the average 1-year price target for CRBU is 20.4 USD with a low forecast of 10.1 USD and a high forecast of 31.5 USD.

What is Caribou Biosciences Inc's Revenue forecast?
Projected CAGR
8%

For the last 3 years the compound annual growth rate for Caribou Biosciences Inc's revenue is 41%. The projected CAGR for the next 3 years is 8%.